Clinical trial
Duration of Postoperative Adjuvant Chemotherapy (3-4 Months Versus 5-6 Months) for Gastric Cancer Patients at Pathological N3 Stage: a Retrospective Study
NCT06194981 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Duration of Postoperative Adjuvant Chemotherapy (3-4 Months Versus 5-6 Months) for Gastric Cancer Patients at Pathological N3 Stage: a Retrospective Study
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 11, 2024
- Completion date
- May 31, 2024
- Enrollment
- 260 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer